(Q24321756)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

main subject

Sp1 transcription factor

1 reference

Histone deacetylase 4

1 reference

Cyclin dependent kinase inhibitor 1A

1 reference

histone deacetylase 1

1 reference

transcription factor binding

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

D Mottet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

S Pirotte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

V Lamour

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

M Hagedorn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

S Javerzat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

A Bikfalvi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

A Bellahcène

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

V Castronovo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

13 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

243-256

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json

Histone deacetylase 1 can repress transcription by binding to Sp1.

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Effects of histone acetylation and DNA methylation on p21( WAF1) regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Rational development of histone deacetylase inhibitors as anticancer agents: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

DNA damage promotes histone deacetylase 4 nuclear localization and repression of G2/M promoters, via p53 C-terminal lysines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Anticancer activities of histone deacetylase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Inhibition of histone deacetylase activity by butyrate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylases (HDACs): characterization of the classical HDAC family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylase inhibitors: overview and perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Vorinostat in cutaneous T-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

The interaction with Sp1 and reduction in the activity of histone deacetylase 1 are critical for the constitutive gene expression of IL-1 alpha in human melanoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Absence of HeLa cell contamination in 169 cell lines derived from human tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylase (HDAC) inhibitor LBH589 increases duration of gamma-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylase 4 is required for TGFbeta1-induced myofibroblastic differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Acetylation and deacetylation of non-histone proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Accessing key steps of human tumor progression in vivo by using an avian embryo model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Nuclear accumulation of histone deacetylase 4 (HDAC4) coincides with the loss of androgen sensitivity in hormone refractory cancer of the prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Activation of p21(WAF1/Cip1) transcription through Sp1 sites by histone deacetylase inhibitor apicidin: involvement of protein kinase C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Differential intranuclear organization of transcription factors Sp1 and Sp3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylases--an important class of cellular regulators with a variety of functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylase 3 represses p15(INK4b) and p21(WAF1/cip1) transcription by interacting with Sp1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylase-1 represses transcription by interacting with zinc-fingers and interfering with the DNA binding activity of Sp1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Functional significance of histone deacetylase diversity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

A simple, rapid, and sensitive DNA assay procedure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

The use of transient chromatin immunoprecipitation assays to test models for E2F1-specific transcriptional activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylase inhibitors open new doors in cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Butyrate Activates the WAF1/Cip1 Gene Promoter through Sp1 Sites in a p53-negative Human Colon Cancer Cell Line

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylase inhibitors in cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Role for histone deacetylase 1 in human tumor cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone Deacetylase Inhibitor Activates the WAF1/Cip1 Gene Promoter through the Sp1 Sites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

HDAC3 overexpression and colon cancer cell proliferation and differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

The transcriptional repressor Sp3 is associated with CK2-phosphorylated histone deacetylase 2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Constitutive expression of the cyclin-dependent kinase inhibitor p21 is transcriptionally regulated by the tumor suppressor protein p53.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Identification of a functional link for the p53 tumor suppressor protein in dexamethasone-induced growth suppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

HDAC4 promotes growth of colon cancer cells via repression of p21.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

p21 is a universal inhibitor of cyclin kinases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Histone deacetylase inhibitors: molecular mechanisms of action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.371

31 March 2020

Identifiers

DOI

10.1038/ONC.2008.371

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

15 January 2020

1024934451

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18850004%20AND%20SRC:MED&resulttype=core&format=json